Zobrazeno 1 - 10
of 30
pro vyhledávání: '"Du-Ping Zheng"'
Autor:
Janet Gare, Ben Toto, Percy Pokeya, Linh-Vi Le, Nick Dala, Namarola Lote, Bangan John, Abel Yamba, Kevin Soli, Joshua DeVos, Heather Paulin, Nick Wagar, Du-Ping Zheng, Takeshi Nishijima, Peniel Boas, Angela Kelly-Hanku, Anup Gurung
Publikováno v:
BMC Infectious Diseases, Vol 22, Iss 1, Pp 1-7 (2022)
Abstract Background Determining the prevalence of pre-treatment HIV drug resistance (PDR) is important to assess the effectiveness of first-line therapies. To determine PDR prevalence in Papua New Guinea (PNG), we conducted a nationally representativ
Externí odkaz:
https://doaj.org/article/ce03124f6e4a4a60af44b970fff04b48
Autor:
Zhiyong Zhou, Kevin Tang, Guoqing Zhang, Nellie Wadonda-Kabondo, Kundai Moyo, Lori A. Rowe, Joshua R. DeVos, Nick Wagar, Du-Ping Zheng, Hongxiong Guo, John Nkengasong, Mike Frace, Scott Sammons, Chunfu Yang
Publikováno v:
African Journal of Laboratory Medicine, Vol 7, Iss 1, Pp e1-e9 (2018)
Background: Minority drug resistance mutations (DRMs) that are often missed by Sanger sequencing are clinically significant, as they can cause virologic failure in individuals treated with antiretroviral therapy (ART) drugs. Objective: This study ai
Externí odkaz:
https://doaj.org/article/13d0f9c6ea3b4931821b0e95467225c9
Autor:
Guoqing Zhang, Joshua DeVos, Sandra Medina-Moreno, Nicholas Wagar, Karidia Diallo, R Suzanne Beard, Du-Ping Zheng, Christine Mwachari, Carolyn Riwa, Boniface Jullu, Ngugi Evelyn Wangari, Mary S Kibona, Lucy W Ng'Ang'A, Elliot Raizes, Chunfu Yang
Publikováno v:
PLoS ONE, Vol 13, Iss 9, p e0203296 (2018)
INTRODUCTION:Surveillance of HIV drug resistance (HIVDR) is crucial to ensuring the continued success of antiretroviral therapy (ART) programs. With the concern of reduced genotyping sensitivity of HIV on dried blood spots (DBS), DBS for HIVDR survei
Externí odkaz:
https://doaj.org/article/01486e7b61ca4fc58e10e95bf3b404a7
Autor:
Du-Ping Zheng, Teryl K. Frey, Joseph P. Icenogle, Shigetaka Katow, Emily S. Abernathy, Ki-Joon Song, Wen-Bo Xu, Vitaly Yarulin, R.G. Desjatskova, Yair Aboudy, Gisela Enders, Margaret Croxson
Publikováno v:
Emerging Infectious Diseases, Vol 9, Iss 12, Pp 1523-1530 (2003)
Phylogenetic analysis of a collection of 103 E1 gene sequences from rubella viruses isolated from 17 countries from 1961 to 2000 confirmed the existence of at least two genotypes. Rubella genotype I (RGI) isolates, predominant in Europe, Japan, and t
Externí odkaz:
https://doaj.org/article/10db8c20a27646a683bedac6d2b7495e
Autor:
Du-Ping Zheng, Margarida Rodrigues, Ebi Bile, Duc B Nguyen, Karidia Diallo, Joshua R DeVos, John N Nkengasong, Chunfu Yang
Publikováno v:
PLoS ONE, Vol 8, Iss 10, p e77649 (2013)
Detection of recent HIV infections is a prerequisite for reliable estimations of transmitted HIV drug resistance (t-HIVDR) and incidence. However, accurately identifying recent HIV infection is challenging due partially to the limitations of current
Externí odkaz:
https://doaj.org/article/dede984077b941eaa58794c2837e9418
Autor:
Lisa C Lindesmith, Eric F Donaldson, Anna D Lobue, Jennifer L Cannon, Du-Ping Zheng, Jan Vinje, Ralph S Baric
Publikováno v:
PLoS Medicine, Vol 5, Iss 2, p e31 (2008)
Noroviruses are the leading cause of viral acute gastroenteritis in humans, noted for causing epidemic outbreaks in communities, the military, cruise ships, hospitals, and assisted living communities. The evolutionary mechanisms governing the persist
Externí odkaz:
https://doaj.org/article/11d27ee54c8f4acebc1a90de63123ba8
Autor:
Nick Dala, Du-Ping Zheng, Janet Gare, Percy Pokeya, Nick Wagar, Anup Gurung, Kevin Soli, Abel Yamba, Bangan John, Heather Paulin, Linh-Vi N. Le, Angela Kelly-Hanku, Ben Toto, Namarola Lote, Peniel Boas, Joshua DeVos, Takeshi Nishijima
Publikováno v:
BMC infectious diseases. 22(1)
Background Determining the prevalence of pre-treatment HIV drug resistance (PDR) is important to assess the effectiveness of first-line therapies. To determine PDR prevalence in Papua New Guinea (PNG), we conducted a nationally representative survey.
Autor:
Hongxiong Guo, Lori A. Rowe, John N. Nkengasong, Kevin Tang, Kundai Moyo, Nellie Wadonda-Kabondo, Joshua DeVos, Du-Ping Zheng, Guoqing Zhang, Zhiyong Zhou, Nick Wagar, Mike Frace, Chunfu Yang, Scott Sammons
Publikováno v:
African Journal of Laboratory Medicine, Vol 7, Iss 1, Pp e1-e9 (2018)
African Journal of Laboratory Medicine
African Journal of Laboratory Medicine, Volume: 7, Issue: 1, Pages: 1-9, Published: 2018
African Journal of Laboratory Medicine
African Journal of Laboratory Medicine, Volume: 7, Issue: 1, Pages: 1-9, Published: 2018
Background: Minority drug resistance mutations (DRMs) that are often missed by Sanger sequencing are clinically significant, as they can cause virologic failure in individuals treated with antiretroviral therapy (ART) drugs. Objective: This study aim
Autor:
Chunfu Yang, Sophearot Prak, Laurent Ferradini, Chandara Mom, Gérard Lesage, Catherine Gaudy-Graffin, Jean-Christophe Plantier, Sovatha Mam, Artur Ramos, Chhivun Mean, Marie Leoz, William Killam, Didier Fontenille, Francis Barin, Benjamin Roche, Sreymom Ken, Du-Ping Zheng, Allison Black, Alexandra Kerleguer, Vonthanak Saphonn, Janin Nouhin, François Rouet, Masami Fujita, Trevor Bedford, Charlotte Gautier, Kerya Phon
Publikováno v:
Clinical Infectious Diseases
Clinical Infectious Diseases, Oxford University Press (OUP), 2018, 66 (11), pp.1733-1741. ⟨10.1093/cid/cix1071⟩
Clinical Infectious Diseases, Oxford University Press (OUP), 2018, 66 (11), pp.1733-1741. ⟨10.1093/cid/cix1071⟩
Background In 2014–2015, 242 individuals aged 2–89 years were newly diagnosed with human immunodeficiency virus type 1 (HIV-1) in Roka, a rural commune in Cambodia. A case-control study attributed the outbreak to unsafe injections. We aimed to re
Autor:
Nicholas Wagar, Joshua DeVos, Lucy Ng’ang’a, Mary S. Kibona, Sandra Medina-Moreno, Du-Ping Zheng, R. Suzanne Beard, Karidia Diallo, Christine Mwachari, Chunfu Yang, Elliot Raizes, Guoqing Zhang, Boniface Jullu, Carolyn Riwa, Ngugi Evelyn Wangari
Publikováno v:
PLoS ONE, Vol 13, Iss 9, p e0203296 (2018)
PLoS ONE
PLoS ONE
Introduction Surveillance of HIV drug resistance (HIVDR) is crucial to ensuring the continued success of antiretroviral therapy (ART) programs. With the concern of reduced genotyping sensitivity of HIV on dried blood spots (DBS), DBS for HIVDR survei